ID2 and cancer: miR-9 restrains the tumorigenic potential and is associated to a better prognosis of glioblastoma [63], it suppresses mesenchymal differentiation of glioblastoma cells and inhibits glioblastoma cancer stem-like cell proliferation [64], which is instead promoted by ID2 [16].